Reanalysis of Omics Datahttps://hdl.handle.net/21.15109/ARP/WG85Q0Zoltán, HegedűsARP2026-03-252026-03-25T11:39:48ZThe rapid proliferation of high-throughput omics technologies has led to an unprecedented accumulation of publicly available biological datasets. While the technical possibilities of reanalyzing such data are widely recognized, the legal, ethical, and institutional frameworks governing their reuse remain complex and often underappreciated. This essay examines the legal and licensing landscape surrounding the reuse of omics data, with particular emphasis on differences between academic and industrial contexts and the specific sensitivities of medical research. Technical considerations are addressed in a supporting role, highlighting how legal constraints shape computational practice.Medicine, Health and Life Sciences2026-03-25Zoltán, Hegedűs2026-03-25CC BY-NC 4.0